Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
EPS for Amphastar Pharmaceuticals (AMPH)
EPS in 2023 (TTM): $2.10
According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.10. In 2022 the company made an earnings per share (EPS) of $1.87 an increase over its 2021 EPS that were of $1.30.
EPS history for Amphastar Pharmaceuticals from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.10 | 12.3% |
| 2022 | $1.87 | 43.85% |
| 2021 | $1.30 | 3521.88% |
| 2020 | $0.03589 | -96.55% |
| 2019 | $1.04 | -900% |
| 2018 | -$0.13 | -238.6% |
| 2017 | $0.09380 | -60.92% |
| 2016 | $0.24 | -500% |
| 2015 | -$0.06000 | -75.74% |
| 2014 | -$0.25 | -116.68% |
| 2013 | $1.48 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | -$13.74 | -754.40% | 🇺🇸 USA |
 SCYNEXIS SCYX | $0.94 | -55.24% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | -$0.11 | -105.24% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$39.56 | -1,983.81% | 🇺🇸 USA |